The stock of IRIDEX (IRIX, Financial), a company specializing in laser medical systems and ophthalmic devices, experienced a significant drop of 5.02%. The stock is currently priced at $1.42 per share, with a trading volume of 18,229 shares and a turnover rate of 0.11%, showing a price fluctuation of 4.01%.
Recent financial reports indicate that IRIDEX achieved a revenue of $12.63 million, though it posted a net loss of $2.68 million, resulting in an earnings per share of -$0.16. The company's gross profit stood at $5.05 million, and it has a price-to-earnings ratio of -2.17. Currently, there are no institutional ratings or recommendations for buying, holding, or selling the stock.
Within the medical devices sector, in which IRIDEX operates, there was an overall decline of 0.05%. Notably, stocks such as Nuwellis, Inc., Biosig Technologies, Inc., and Integra LifeSciences showed significant gains. Nuwellis, Inc., Catheter Precision, Inc., and Tenon Medical, Inc. were highly active, with turnover rates of 4736.66%, 63.45%, and 46.35%, respectively. Nuwellis, Inc., Baird Medical Investment Holdings Ltd, and Biosig Technologies, Inc. had the highest volatility, with price fluctuations of 156.61%, 30.73%, and 26.13% respectively.
IRIDEX Corporation focuses on the development, manufacturing, and sales of laser medical systems and ophthalmic devices, powered by its proprietary micropulse technology. The company is involved in sales across consoles, delivery devices, consumables, and service and support activities. Its primary revenue comes mainly from the Americas, including the U.S., Europe, and regions excluding the U.S. and Asia-Pacific.
